Loading...
This record has been deleted. Since it is linked to a published record, it is available here for reference purposes only.
Click here to view the deleted recordThis document has been updated. This is not the latest published version. Click here to view the latest version of the record.
Internationally Recognized Certificates of Compliance
(IRCC)
last updated: 20 Sep 2019
ABSCH-IRCC-IN-247758-1
Competent National Authority:National Biodiversity Authority ()5th Floor, TICEL Biopark, CSIR Road, TaramaniChennai, Tamilnadu
600 113, IndiaPhone: +91 44 2254 2777,Fax: +91 44 2254 1200,Website: http://www.nbaindia.org,
India/NBA/Appl/9/1091
Application in Form-III for seeking approval for the invention on “A topical medicinal composition” for obtaining IP Rights in India and South Africa
Indian Patent Application Number: 4086/MUM/2014
South Africa: 2015/09173
Indian Patent Application Number: 4086/MUM/2014
South Africa: 2015/09173
10 Feb 2018
Yes
Competent National Authority:National Biodiversity Authority ()5th Floor, TICEL Biopark, CSIR Road, TaramaniChennai, Tamilnadu
600 113, IndiaPhone: +91 44 2254 2777,Fax: +91 44 2254 1200,Website: http://www.nbaindia.org,
Confidential information
Person:Dr Mohan DewanAdvocate, Patent & Trademark Attorney, R.K. Dewan & Co Trade Marks and patent Attorneys,Podar Chambers, S.A. Brelvi Road,Port Mumbai, Maharashtra
400 001, IndiaPhone: +9122 22661662,Fax:Email: rkd@rkdewan.com, rkdewanchennai@vsnl.net,Website:
-
Organization:
Ari Healthcare Private Limited
()
|
ABSCH-CON-IN-239783-1
This document has been updated. This is not the latest published version.
Click here to view the latest version of the record.
Organization:Ari Healthcare Private Limited ()Private sector (business and industry)Office No.106, 1st Floor, S. No.1, world Trade Centre, Tower one, opposite EON SEZ,Kharadi,Pune, Maharashtra
411 004, IndiaPhone: +9122 22661662,Fax:Email: info@arihealthcare.in,Website:
Confidential information
Yes
1. The user shall notify the NBA within 60 days from the date of grant of IPR.
2. If the user himself commercializes the process/product/innovation, the monetary sharing shall be 0.4 % on the annual gross ex-factory sale minus government taxes.
3. The user shall inform the NBA about any commercialization made on the IP Rights granted.
4. The user shall submit annual report to NBA as per the terms and conditions agreed upon.
For obtaining IP Rights on the Invention on “A topical medicinal composition” for obtaining IP Rights in India and South Africa.
Biological Resources
1. Lodh tree - Symplocos racemasa
2. Vacha - Acorus calamus
3. Dhanyaka - Coriandrum sativum
4. Mulethi - Glycyrrhiza glabra
5. Shamali - Salmalia malabarica
6. Daruhaldi - Berberis aristata
7. Jatiphal - Myristica fragrans
8. Manjishtha - Rubia cordifolia
Confidential information
- Commercial
1. If the user assigns/licenses the process/product/innovation to a third party for commercialization, the user shall pay to NBA 4.0% of the fee received (in any form including the license / assignee fee) and 4.0% of the royalty amount received annually from the assignee/licensee.
2. In case the user assigns or transfers the IPR in whole or in part to any person, whether voluntarily or involuntarily, the user undertakes to attach this agreement as an appendix to the assignment instrument, which shall be binding upon such person.
| Unique identifier | Status | Date |
|---|---|---|
| ABSCH-IRCC-IN-247758-1 |
REVOKED
OLD VERSION
PUBLISHED
DELETED
|
Sujata Arora (sujata@nic.in)
20 Sep 2019 13:58 on 20 Sep 2019 13:58
|
